In line with previous Mendelian randomization studies, the overall effect of non-ADIPOQ variants on T2D or glycaemic traits together with null association of ADIPOQ variants is compatible with pleiotropic effects of adiponectin on T2D (42). This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.